Research view

Title: THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients
Author: Baddoura R, Ourgandjian H
Abstract:
BACKGROUND: Conventional antipsychotics have relatively moderate efficacy against schizophrenic negative symptoms and are associated with significant adverse events. OBJECTIVES: To assess the clinical safety and efficacy of Solian (amisulpride), an aty
Journal: J Med Liban. 2004 Apr-Jun;52(2):78-85